Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2010 - 2026)

Zimmer Biomet Holdings' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $293.9 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $293.9 million in Q1 2026; TTM through Mar 2026 was $293.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $477.1 million, up 27.84% from the prior year.
• Accumulated Expenses declined to $293.9 million in Q1 2026 per ZBH's latest filing, from $477.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $582.3 million in Q4 2022 and bottomed at $184.5 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $333.6 million (2024), against an average of $349.4 million.
• Across the five-year window, Accumulated Expenses slipped 28.37% in 2023 and rose 27.84% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $582.3 million in 2022, then decreased by 28.37% to $417.1 million in 2023, then retreated by 10.53% to $373.2 million in 2024, then gained by 27.84% to $477.1 million in 2025, then sank by 38.4% to $293.9 million in 2026.
• Per Business Quant, the three latest ZBH Accumulated Expenses figures stand at $293.9 million (Q1 2026), $477.1 million (Q4 2025), and $373.2 million (Q4 2024).